Seoul, Oct 7 (IANS) South Korean researchers have identified a significantly higher risk of multiple new-onset autoimmune and autoinflammatory connective-tissue disorders after Covid-19 infection.
New York, Oct 7 (IANS) During pregnancy, it’s not women’s bodies alone that undergo change. Turns out the brain also gets ‘rewired’ to prepare for motherhood, finds a study in mice.
New York, Oct 7 (IANS) A team of scientists have discovered the impact of a multitude of genes that are associated with neurodevelopmental disorders, including autism, but whose effects on human brain development were previously unknown.
New York, Oct 7 (IANS) Researchers have demonstrated "in theory" that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumour to refocus the body's immune system against the cancer, effectively halting it and preventing its recurrence.
New York, Oct 7 (IANS) Researchers, including one of Indian-origin, have shown for the first time that mothers are much less likely to transmit a common virus known to cause miscarriages and birth defects if they are exposed to the virus prior to becoming pregnant.
Mumbai, Oct 6 (IANS) The Bombay High Court on Friday observed that the Maharashtra government cannot shift the burden of ensuring public healthcare on private hospitals, and directed filling up of various vacancies in the state medicare system.
New Delhi, Oct 6 (IANS) India had 3·02 million preterm births in 2020 -- the highest worldwide, and accounting for over 20 per cent of all preterm births globally, according to a study published in the journal Lancet.
Mumbai, Oct 5 (IANS) Under fire from the opposition over deaths in hospitals, Maharashtra Chief Minister Eknath Shinde on Thursday ordered all Collectors to visit the government hospitals in their districts and submit a status report immediately.
New York, Oct 5 (IANS) Fathers also suffer from postpartum depression, and a new pilot study suggests they can and should be screened for the condition.
New York, Oct 4 (IANS) Moderna on Thursday announced positive interim results from the Phase 1/2 trial of its investigational combination vaccine against influenza and Covid-19.
